MXCT Profile
MaxCyte, Inc. is a global life sciences company specializing in the development and commercialization of advanced cell therapies and related technologies. Headquartered in Rockville, Maryland, the company operates at the forefront of cell engineering, providing innovative tools and solutions to accelerate the discovery, development, and production of cell-based therapies.
MaxCyte’s core offerings include a range of electroporation instruments designed to meet diverse needs in cell therapy and biomanufacturing. The ExPERT ATx system facilitates static electroporation for small to medium-scale transfections, which is ideal for laboratory and early-stage research applications. The ExPERT STx system supports flow electroporation, enabling efficient protein production and drug development, as well as the expression of therapeutic targets for cell-based assays.
For large-scale therapeutic applications, MaxCyte offers the ExPERT GTx, a flow electroporation system designed to handle higher volumes and achieve greater efficiency in transfection processes. Additionally, the ExPERT VLx system is tailored for very large volume cell engineering, further expanding the company’s capabilities in high-throughput and large-scale applications. Complementing these systems, MaxCyte provides disposable processing assemblies (PAs) for cell processing and electroporation, along with essential accessories such as electroporation buffer solutions and software protocols.
Founded in 1998, MaxCyte has established itself as a leader in the field of cell therapy through its commitment to advancing cell engineering technologies. Its comprehensive suite of products supports a broad range of applications across research, drug development, and therapeutic manufacturing, positioning the company as a key player in the evolving landscape of cell-based treatments.
|
